RSS

Lundbeck

Global pharma player Lundbeck has announced a project with information analytics company Elsevier to help it improve the way it manages data and ultimately speed up drug development. Read more

News

Lundbeck has signed a definitive agreement to acquire biopharma company, Prexton Therapeutics, obtaining the global rights for foliglurax — a treatment for Parkinson’s that has recently entered clinical Phase II testing. Read more

News

A drug that was believed to be a promising new therapeutic option for suffers of Alzheimer’s (idalopirdine) — from the Danish pharma company, Lundbeck — has failed to show clinical benefit in three randomised trials. Read more

News